Experience

Sandoz Inc. v. Boehringer Ingelheim International GmbH et al.

Sandoz Inc.

Boehringer Ingelheim International GmbH et al.

Successfully represented patent owner in post grant review (PGR) challenge related to Skyrizi®.

Sandoz Inc. v. Boehringer Ingelheim International GmbH et al., PGR2022-00037, PTAB, Judges Newman, Obermann, Worth

Related Professionals

William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Kassandra M. Officer
Partner
Washington, DC
+1 202 408 4270
Email

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Life Sciences

Pharmaceutical

Biotechnology

Biologics

Related Experiences

AbbVie Inc. v. Boehringer Ingelheim International GmbH

AbbVie Inc.

Sandoz, Inc. et al v. Pharmacyclics LLC

Pharmacyclics LLC; Janssen Biotech, Inc.

Lo v. Quake

Sequenom, Inc. et al

Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.

Grünenthal GmbH et al.

Orbital Australia Pty. Ltd. et al. v. Daimler AG, Mercedes-Benz USA, LLC, Mercedes-Benz US International, Inc., Robert Bosch GmbH, and Robert Bosch LLC

Robert Bosch GmbH et al.

Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.

Biogen MA Inc. et al.

BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al.

BioDelivery Sciences International, Inc. et al.

Pinkerton Tobacco Co., LP et al. v. Kretek International, Inc., et al.

Swedish Match North America LLC et al.

BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.

BioDelivery Sciences International, Inc. et al.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.